Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Cadrenal Cvkd Stock Good For Active Traders Price At 4.96 Down 0.20 20260410 Allo Q4 2025 Earnings Allogene Therapeutics Inc. Beats Eps Estimates With Zero Revenue 20260403 1 Is Cheetah Net Ctnt Stock Trending Down Price At 1.45 Up 9.02 20260404 Is Beyond Meat Bynd Stock In An Uptrend Price At 0.59 Down 1.33 20260410 Are Insiders Buying Or Selling Bluejay Diag Bjdx Stock Price At 1.95 Up 3.17 20260402 Tdg Gains Ground As Investors Pile In 20260401 1 Is Invesco Vki Stock Trending Down Price At 8.98 Down 1.15 20260413 Is Lionsgate Lion Stock Near Resistance Price At 9.79 Up 0.72 20260408 Is Pursuit Prsu Stock Breaking Out Price At 39.51 Up 1.75 20260407 Is Institutional Money Flowing Into Pfizer Pfe Stock Price At 26.91 Down 0.06 20260413 Is Happy City Hchl Stock Good For Passive Investors Price At 1.62 Up 3.50 20260406 Is Wetour Weto Stock Expanding Price At 0.52 Up 7.34 20260413 Is Northrim Bancorp Nrim Stock Worth Buying Now Price At 24.60 Down 0.81 20260413 Can Cricut Crct Stock Recover Now Price At 4.08 Up 2.00 20260406 Will New Era Nuaiw Stock Outperform Peers Price At 1.78 Down 3.51 20260406 Is Abbvie Abbv Stock Cheap At Current Price Price At 207.12 Down 0.82 20260406 Is Mueller Industries Mli Stock Competitive Now Price At 111.44 Up 0.65 20260406 INBX Inhibrx Biosciences Inc reports narrow Q4 2025 EPS beat shares rise 616 percent on upbeat investor sentiment Market Update Technology leads broad market gains while consumer sector lags behind WY Weyerhaeuser Company reports narrower Q4 2025 loss than expected shares fall 23 percent on year over year revenue decline ASIC Ategrity Specialty Insurance Company Holdings reports robust Q4 2025 earnings with 299 percent EPS beat and 234 percent annual revenue growth Nuvation Bio NUVB Stock Financial Update Market Focus 20260418 Shengfeng SFWL Stock Slides 625 20260418 Is Alphatec ATEC stock changing direction 259 20260418 BioNexus Lab BGLC Risk Reward Ratio BioNexus Gene Lab posts strong revenue net loss Is Chatham REIT CLDT stock a viable buying opportunity 234 20260418 Beazer Homes BZH Stock Bond Trade Investor Interest 20260420 Concentra CON Stock Retail Sales Investors Pile In 20260423 What could move Modine MOD stock next Slight Rise 20260420 DOLE Dole tops Q4 2025 EPS expectations shares rise modestly on 82 percent year over year revenue growth SCM Stellus records steep Q4 2025 EPS miss and 375 YoY revenue drop shares dip slightly US Bancorp USB Advanced Micro Devices Inc AMD Rides AI CPU Demand Tailwind Amid Peer Intels INTC Comeback Narrative Amazoncom Inc AMZN Akebia AKBA Stock Outlook and Forecast Q4 2025 EPS Misses Views Republic RDAGU Market Share Trend RDAGU Latest Quarter Earnings Republic has no operating results as it pursues SPAC merger targets MGEE MGE Energy reports 98 percent Q4 2025 revenue growth shares rise 126 percent despite narrow EPS miss RPRX Royalty posts Q4 2025 87 percent EPS beat and 51 percent YoY revenue gain shares edge down Valero Energy Corporation VLO Favorable Earnings Setup Signals Potential Q1 2026 Beat Amid Bifurcated Energy Sector Performance Is Apex APXTW stock gaining traction Voyager Therapeutics VYGR Stock Support Breakdown Risk Q4 2025 EPS Beats Forecasts Is Cabaletta CABA stock a good opportunity for entry Institutional Selling 20260427 Is Rexford REXRC stock facing uncertainty Amgen Inc AMGN Q1 2026 Earnings Robust Growth Pipeline Offsets Legacy Product Pressures LNAI Lunai Bioworks reports Q1 2026 EPS of negative 008 shares slip 081 percent with no analyst earnings estimates How is the market affecting Borr Drilling BORR stock today Borr Drilling beats EPS by 100 to post break even quarterly results McDonalds Corporation MCD Franchise Real Estate Moat Underpins Bullish LongTerm Investment Thesis American Tower Corporation AMT Q1 2026 AFFO Revenue Top Consensus Raises FullYear Guidance Amid Bullish Brokerage Sentiment AISP Airship AI Holdings Inc reports far worse than expected Q3 2025 per share loss pushing its shares down 237 today BCRX BioCryst Pharmaceuticals Inc drops 238 percent post Q4 2025 EPS miss despite 94 percent year over year revenue growth